NOVAMINE 8.5% Drug Patent Profile
✉ Email this page to a colleague
When do Novamine 8.5% patents expire, and when can generic versions of Novamine 8.5% launch?
Novamine 8.5% is a drug marketed by Hospira Inc and is included in one NDA.
The generic ingredient in NOVAMINE 8.5% is amino acids. There are three hundred and fifty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the amino acids profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Novamine 8.5%
A generic version of NOVAMINE 8.5% was approved as amino acids by B BRAUN on April 13th, 2012.
Summary for NOVAMINE 8.5%
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NOVAMINE 8.5% at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NOVAMINE 8.5%
US Patents and Regulatory Information for NOVAMINE 8.5%
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira Inc | NOVAMINE 8.5% | amino acids | INJECTABLE;INJECTION | 017957-002 | Aug 9, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |